
Baxter International Inc.
BAX
31.21
USD+0.01
(+0.03%)Day's range
31.17
31.311
52 wk Range
26.25
40.49
Key ratios
Statements Highlights
Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
---|---|---|---|---|---|---|
Total Revenue | 11,673,000,000 | 12,784,000,000 | 15,113,000,000 | 14,813,000,000 | 10,636,000,000 | |
Gross Profit | 4,587,000,000 | 5,105,000,000 | 5,397,000,000 | 4,975,000,000 | 3,984,000,000 | |
Operating Income | 603,000,000 | 779,000,000 | -549,000,000 | 390,000,000 | -112,000,000 | |
Net Income | 1,102,000,000 | 1,284,000,000 | -2,421,000,000 | 2,656,000,000 | -649,000,000 | |
Total Assets | 20,019,000,000 | 33,521,000,000 | 28,287,000,000 | 28,276,000,000 | 25,782,000,000 | |
Total Current Liabilities | 3,333,000,000 | 4,236,000,000 | 4,745,000,000 | 6,503,000,000 | 6,511,000,000 | |
Total Equity | 8,726,000,000 | 9,121,000,000 | 5,895,000,000 | 8,468,000,000 | 7,024,000,000 | |
Free Cash Flow | 1,159,000,000 | 1,479,000,000 | 532,000,000 | 1,034,000,000 | 559,000,000 | |
Cash from Operations | 1,868,000,000 | 2,222,000,000 | 1,211,000,000 | 1,726,000,000 | 1,019,000,000 | |
Cash from Investing | -1,179,000,000 | -11,200,000,000 | -931,000,000 | 3,213,000,000 | -626,000,000 | |
Cash from Financing | -345,000,000 | 8,245,000,000 | -1,438,000,000 | -3,489,000,000 | -1,081,000,000 | |
Net Change in Cash | 401,000,000 | -780,000,000 | -1,234,000,000 | 1,476,000,000 | -784,000,000 |
Analyst Recomendations
Overall consensus
Buy